Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACCURATE: Dextenza in Ocular Surface Disease
NCT04237012Phase 4Completed
- Sponsor
- The Eye Centers of Racine and Kenosha
- Start
- Dec 2019
- Primary completion
- Dec 2021
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ozurdex in dry eye syndrome (DED), sponsored by The Eye Centers of Racine and Kenosha. Started Dec 2019; status: completed.
02
Drugs
ozurdex
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT04237012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04237012.